Literature DB >> 31455670

Risk Factors for Triple-Negative Breast Cancer among Latina Women.

Laura Rey-Vargas1,2, María Carolina Sanabria-Salas1, Laura Fejerman3, Silvia J Serrano-Gómez4.   

Abstract

Breast cancer is the most common cancer in Latina women. Although they have a lower incidence of the disease when compared with other population groups such as non-Hispanic white and African-American women, some studies have shown that Latina women have a higher risk of mortality when compared with non-Hispanic white women. This phenomenon can be explained in part by the higher prevalence of aggressive subtypes in Latina women, particularly the triple negative. Such differences in breast cancer-intrinsic subtype distribution between population groups might be a consequence of a variety of risk factors differentially present among population groups. Here, we provide a full description of risk factors that might be associated with the high prevalence of the triple-negative subtype in Latina women. We assessed demographic (socioeconomic status), modifiable (reproductive patterns, obesity, and physical activity), and nonmodifiable (family history, germline BRCA mutations, and genetic ancestry) risk factors. The observed inconsistencies among different epidemiologic studies in Latinas warrant further research focused on breast cancer subtype-specific risk factors in this population. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31455670     DOI: 10.1158/1055-9965.EPI-19-0035

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Analysis of risk factors associated with breast cancer in women: a systematic review and meta-analysis.

Authors:  Hulin Liu; Suling Shi; Jinnan Gao; Jun Guo; Min Li; Linying Wang
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

2.  Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.

Authors:  Katie M Marker; Valentina A Zavala; Tatiana Vidaurre; Paul C Lott; Jeannie Navarro Vásquez; Sandro Casavilca-Zambrano; Mónica Calderón; Julio E Abugattas; Henry L Gómez; Hugo A Fuentes; Ruddy Liendo Picoaga; Jose M Cotrina; Silvia P Neciosup; Carlos A Castañeda; Zaida Morante; Fernando Valencia; Javier Torres; Magdalena Echeverry; Mabel E Bohórquez; Guadalupe Polanco-Echeverry; Ana P Estrada-Florez; Silvia J Serrano-Gómez; Jenny A Carmona-Valencia; Isabel Alvarado-Cabrero; María Carolina Sanabria-Salas; Alejandro Velez; Jorge Donado; Sikai Song; Daniel Cherry; Lizeth I Tamayo; Scott Huntsman; Donglei Hu; Roberto Ruiz-Cordero; Ronald Balassanian; Elad Ziv; Jovanny Zabaleta; Luis Carvajal-Carmona; Laura Fejerman
Journal:  Cancer Res       Date:  2020-04-03       Impact factor: 12.701

3.  A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors.

Authors:  Claire C Conley; Eida M Castro-Figueroa; Laura Moreno; Julie Dutil; Jennifer D García; Carolina Burgos; Charité Ricker; Jongphil Kim; Kristi D Graves; Kimlin Tam Ashing; Gwendolyn P Quinn; Hatem Soliman; Susan T Vadaparampil
Journal:  J Genet Couns       Date:  2020-09-16       Impact factor: 2.537

4.  Circular RNA profiling facilitates the diagnosis and prognostic monitoring of breast cancer: A pair-wise meta-analysis.

Authors:  Yanqing Ma; Xiaobin Niu; Sha Yan; Yuchun Liu; Ruihua Dong; Yongwei Li
Journal:  J Clin Lab Anal       Date:  2020-11-07       Impact factor: 2.352

5.  Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior.

Authors:  Rubén Rodríguez-Bautista; Claudia H Caro-Sánchez; Paula Cabrera-Galeana; Gerardo J Alanis-Funes; Everardo Gutierrez-Millán; Santiago Ávila-Ríos; Margarita Matías-Florentino; Gustavo Reyes-Terán; José Díaz-Chávez; Cynthia Villarreal-Garza; Norma Y Hernández-Pedro; Alette Ortega-Gómez; Luis Lara-Mejía; Claudia Rangel-Escareño; Oscar Arrieta
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.